A vaccine for adult shingles was approved by the FDA in 2006 and is in use today. Perversely, recent data shows that delivery of the adult Shingles vaccine has been a challenge. This includes delivery to older populations, on whom the Shingles virus typically realizes its greatest impact. With Baby Boomers nearing the age of greatest risk, how can physicians and other medical professionals improve their dialogue with patients about this vaccine? Host Dr. Mark Nolan Hill examines strategies to improve immunization rates for adult Shingles with Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine at Vanderbilt University School of Medicine.
Boosting Immunization Rates for Adult Shingles
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Overview
A vaccine for adult shingles was approved by the FDA in 2006 and is in use today. Perversely, recent data shows that delivery of the adult Shingles vaccine has been a challenge. This includes delivery to older populations, on whom the Shingles virus typically realizes its greatest impact. With Baby Boomers nearing the age of greatest risk, how can physicians and other medical professionals improve their dialogue with patients about this vaccine? Host Dr. Mark Nolan Hill examines strategies to improve immunization rates for adult Shingles with Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine at Vanderbilt University School of Medicine.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Pulmonary Hypertension Management: Practice Trends and Updates
Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients
Reducing the Risk of Postpartum Depression Through Sleep Interventions
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Improving the IUD Experience: Evidence-Based Pain Management Approaches
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?